Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in early cerebral adrenoleukodystrophy can stabilize neurologic function and improve survival but has associated risks including transplant-related mortality (TRM), graft failure, and graft-versus-host disease (GVHD). An observational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiesa, Robert, Boelens, Jaap Jan, Duncan, Christine N., Kühl, Jörn-Sven, Sevin, Caroline, Kapoor, Neena, Prasad, Vinod K., Lindemans, Caroline A., Jones, Simon A., Amartino, Hernan M., Algeri, Mattia, Bunin, Nancy, Diaz-de-Heredia, Cristina, Loes, Daniel J., Shamir, Esther, Timm, Alison, McNeil, Elizabeth, Dietz, Andrew C., Orchard, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905699/
https://www.ncbi.nlm.nih.gov/pubmed/34781360
http://dx.doi.org/10.1182/bloodadvances.2021005294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905699/
https://www.ncbi.nlm.nih.gov/pubmed/34781360
http://dx.doi.org/10.1182/bloodadvances.2021005294

Ejemplares similares